A. Iriondo
4 Papers
60 Citations
A. Iriondo is an academic researcher. The author has contributed to research in topics: Transplantation & Leukemia. The author has an hindex of 4, co-authored 4 publications.
Chat about Author
Papers
Genotypically nonidentical related donors for transplantation of patients with myelodysplastic syndromes: comparison with unrelated donor transplantation and autologous stem cell transplantation.
T. de Witte,F Pikkemaat,Jo Hermans,A. van Biezen,S Mackinnan,Jeroen J. L. M. Cornelissen,Alois Gratwohl,Michel Delforge,A. Iriondo,M Kuentz,J L Harousseau,Axel A. Fauser,Hannes Wandt,Runde,Dietger Niederwieser,J. F. Apperley +15 more
TL;DR: The results of transplantation with mismatched family donors were comparable to those obtained with unrelated donor transplantation, and suggests that nonidentical family donors may be considered if a fully matched unrelated donor is not available.
39
Splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia.
Alois Gratwohl,Jo Hermans,Anja van Biezen,William Arcese,L. Debusscher,Peter B. Ernst,Augustin Ferrant,Francesco Frassoni,G. Gahrton,A. Iriondo,H. J. Kolb,Hartmut Link,Dietger Niederwieser,Tapani Ruutu,Anton Schattenberg,Norbert Schmitz,Wolfgang Siegert,A. Torres-Gomez,Jean-Paul Vernant,F. E. Zwaan,J. F. Apperley +20 more
TL;DR: An advantage in splenic irradiation prior to transplantation for CML in this subgroup of patients is suggested and illustrates the need for tailored therapy.
Splenic Irradiation before Bone Marrow Transplantation for Chronic Myeloid Leukemia: Update of a Prospective Randomized Study
A. Gratwohl,Jo Hermans,Anja van Biezen,William Arcese,T. de Witte,L Debusscher,P. Ernst,Augustin Ferrant,Francesco Frassoni,G. Gahrton,A. Iriondo,Kolb Hj,Hartmut Link,Dietger Niederwieser,T. Ruutu,N. Schmitz,Wolfgang Siegert,A. Torres-Gomez,J P Vernant,F. E. Zwaan +19 more
TL;DR: Recovery of peripheral white blood cell counts but not of platelet counts was significantly faster in patients with SI+, but a small benefit does not justify routine splenic irradiation prior to BMT, in CML.
5
Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: a retrospective registry study from the European Group for Blood and Marrow Transplantation (EBMT)
Bo Björkstrand,H. Svensson,H. Goldschmidt,Per Ljungman,Jane F. Apperley,Franco Mandelli,Robert Marcus,Marc Boogaerts,A Alegre,Kari Remes,Jeroen J. L. M. Cornelissen,J. Bladé,Stig Lenhoff,A. Iriondo,Kristina Carlson,Liisa Volin,Timothy Littlewood,Anthony H. Goldstone,J F San Miguel,A.V.M.B. Schattenberg,Gösta Gahrton +20 more
TL;DR: IFN maintenance treatment after autologous stem cell transplantation (ASCT) for multiple myeloma was associated with better OS and PFS, and this might justify possible differences in quality of life due to adverse effects of interferon treatment.